Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jiangsu
- Most recent report
- 6-K, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 192 filings
- On EDGAR
- CIK 1818838
- Fiscal year ends
- December
- Filer status
- Accelerated filer, Emerging growth company
Financials 8 of 75
- 6-K Report a foreign issuer made public elsewhere Nov 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 25, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 22, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 10, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 12, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 6, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 17, 2026
Prospectuses and Registrations 8 of 11
- 424B5 Prospectus supplement for an offering Apr 2, 2026
- 424B5 Prospectus supplement for an offering Apr 2, 2026
- 424B3 Prospectus supplement for an offering Jan 9, 2026
- F-3 Oct 31, 2025
- 424B5 Prospectus supplement for an offering May 30, 2025
- F-3 May 9, 2025
- 424B5 Prospectus supplement for an offering Mar 29, 2024
- F-3 Apr 26, 2022
Ownership 8 of 56
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Sep 25, 2026
- 4 Insider reported a trade Sep 17, 2026
- 144/A Notice of a proposed sale of restricted stock, amended Aug 20, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 17, 2026
- 4 Insider reported a trade Aug 17, 2026
Other 8 of 50
- EFFECT Notice that a registration became effective Jan 9, 2026
- CORRESP Reply to SEC staff Jan 7, 2026
- EFFECT Notice that a registration became effective May 30, 2025
- CORRESP Reply to SEC staff May 28, 2025
- CORRESP Reply to SEC staff May 23, 2025
- F-3/A Amended filing May 23, 2025
- UPLOAD Comment letter from SEC staff May 21, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended Nov 7, 2024
Everything here comes from Adagene Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.